These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15272287)

  • 41. Third, fourth, and sixth cranial nerve palsies following closed head injury.
    Dhaliwal A; West AL; Trobe JD; Musch DC
    J Neuroophthalmol; 2006 Mar; 26(1):4-10. PubMed ID: 16518159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?
    Kuo HC
    Urology; 2006 Nov; 68(5):993-7; discussion 997-8. PubMed ID: 17113890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy.
    Rivard PF; Nugent AC; Symons FJ
    Clin J Pain; 2009 Jun; 25(5):413-7. PubMed ID: 19454875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC; Bowen B; Liu J; Brin MF
    Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Augmented vertical recti transposition with intraoperative botulinum toxin for complete and chronic sixth nerve palsy.
    Nabie R; Andalib D
    Eye (Lond); 2017 Jan; 31(1):148-151. PubMed ID: 27813529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis.
    Ozcan C; Vayisoglu Y; Doğu O; Görür K
    Am J Otolaryngol; 2006; 27(5):314-8. PubMed ID: 16935174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
    Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
    BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy].
    Alataş N; Yazgan P; Oztürk A; San I
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(2):49-53. PubMed ID: 16763416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial treatment outcomes in chronic sixth nerve palsy.
    Holmes JM; Leske DA; Christiansen SP
    J AAPOS; 2001 Dec; 5(6):370-6. PubMed ID: 11753258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin A: a novel adjunct treatment for debilitating habit cough in children.
    Sipp JA; Haver KE; Masek BJ; Hartnick CJ
    Ear Nose Throat J; 2007 Sep; 86(9):570-2. PubMed ID: 17970150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The natural history of acute traumatic sixth nerve palsy or paresis.
    Holmes JM; Droste PJ; Beck RW
    J AAPOS; 1998 Oct; 2(5):265-8. PubMed ID: 10646746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does Botulinum toxin have a role in the treatment of small-angle esotropia?
    Dawson EL; Lee JP
    Strabismus; 2004 Dec; 12(4):257-60. PubMed ID: 15545143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report.
    Xiao Z; Zhang F; Cui Z
    Aesthetic Plast Surg; 2009 May; 33(3):409-12. PubMed ID: 19357910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of laryngo-tracheal injuries associated with craniomaxillofacial trauma.
    Verschueren DS; Bell RB; Bagheri SC; Dierks EJ; Potter BE
    J Oral Maxillofac Surg; 2006 Feb; 64(2):203-14. PubMed ID: 16413891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin type A in prophylactic treatment of migraine.
    Anand KS; Prasad A; Singh MM; Sharma S; Bala K
    Am J Ther; 2006; 13(3):183-7. PubMed ID: 16772757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxin for sixth nerve palsies in children with brain tumors.
    Kerr NC; Hoehn MB
    J AAPOS; 2001 Feb; 5(1):21-5. PubMed ID: 11182668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
    Mascarenhas F; Cocuzza M; Gomes CM; Leão N
    Neurourol Urodyn; 2008; 27(4):311-4. PubMed ID: 17914742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
    Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
    Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.